Literature DB >> 18985655

Soy, isoflavones, and prostate cancer.

Le Jian1.   

Abstract

Prostate cancer has marked geographic variations between countries. Genetic, epigenetic, and environmental factors co-contribute to the development of the cancer. The association between dietary factors and prostate cancer has been investigated and one explanation for the low incidence of the cancer in Asia might be high consumption of fresh vegetables including soybean and its products. Soybean is a species of legume contain high amount of isoflavones including genistein, daidzein, glycitein, and equol, which have a prophylactic effect on prostate cancer. In this article, epidemiological and laboratory studies on the relationship between soybeans, isoflavones and prostate cancer are reviewed and large scale multiethnic epidemiological studies are recommended.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18985655     DOI: 10.1002/mnfr.200800167

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  17 in total

Review 1.  Dietary agents in cancer prevention: an immunological perspective.

Authors:  Ya Ying Zheng; Bharathi Viswanathan; Pravin Kesarwani; Shikhar Mehrotra
Journal:  Photochem Photobiol       Date:  2012-03-30       Impact factor: 3.421

2.  Genistein increases estrogen receptor beta expression in prostate cancer via reducing its promoter methylation.

Authors:  Abeer M Mahmoud; Umaima Al-Alem; Mohamed M Ali; Maarten C Bosland
Journal:  J Steroid Biochem Mol Biol       Date:  2015-04-27       Impact factor: 4.292

Review 3.  Estrogens and prostate cancer: etiology, mediators, prevention, and management.

Authors:  Shuk-Mei Ho; Ming-Tsung Lee; Hung-Ming Lam; Yuet-Kin Leung
Journal:  Endocrinol Metab Clin North Am       Date:  2011-07-07       Impact factor: 4.741

Review 4.  Nutraceuticals and prostate cancer prevention: a current review.

Authors:  Greg Trottier; Peter J Boström; Nathan Lawrentschuk; Neil E Fleshner
Journal:  Nat Rev Urol       Date:  2009-12-08       Impact factor: 14.432

Review 5.  Does equol production determine soy endocrine effects?

Authors:  Dana Shor; Thozhukat Sathyapalan; Stephen L Atkin; Natalie J Thatcher
Journal:  Eur J Nutr       Date:  2012-02-25       Impact factor: 5.614

6.  7,3',4'-Trihydroxyisoflavone inhibits epidermal growth factor-induced proliferation and transformation of JB6 P+ mouse epidermal cells by suppressing cyclin-dependent kinases and phosphatidylinositol 3-kinase.

Authors:  Dong Eun Lee; Ki Won Lee; Nu Ry Song; Sang Kwon Seo; Yong-Seok Heo; Nam Joo Kang; Ann M Bode; Hyong Joo Lee; Zigang Dong
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

7.  Xeno-oestrogens and phyto-oestrogens are alternative ligands for the androgen receptor.

Authors:  Hao Wang; Jiang Li; Yang Gao; Ying Xu; Ying Pan; Ichiro Tsuji; Zi-Jie Sun; Xiao-Meng Li
Journal:  Asian J Androl       Date:  2010-05-03       Impact factor: 3.285

8.  Soy content of basal diets determines the effects of supplemental selenium in male mice.

Authors:  Trevor E Quiner; Heather L Nakken; Brock A Mason; Edwin D Lephart; Chad R Hancock; Merrill J Christensen
Journal:  J Nutr       Date:  2011-10-26       Impact factor: 4.798

9.  A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients.

Authors:  Edward Messing; Jason R Gee; Daniel R Saltzstein; KyungMann Kim; Anthony diSant'Agnese; Jill Kolesar; Linda Harris; Adrienne Faerber; Thomas Havighurst; Jay M Young; Mitchell Efros; Robert H Getzenberg; Marcia A Wheeler; Joseph Tangrea; Howard Parnes; Margaret House; J Erik Busby; Raymond Hohl; Howard Bailey
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-31

10.  Bioavailability of phytochemical constituents from a novel soy fortified lycopene rich tomato juice developed for targeted cancer prevention trials.

Authors:  Torsten Bohn; Michelle Blackwood; David Francis; Qingguo Tian; Steven J Schwartz; Steven K Clinton
Journal:  Nutr Cancer       Date:  2011-11-18       Impact factor: 2.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.